These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

308 related items for PubMed ID: 2016797

  • 1. Activation by the protein-bound polysaccharide PSK (krestin) of cytotoxic lymphocytes that act on fresh autologous tumor cells and T24 human urinary bladder transitional carcinoma cell line in patients with urinary bladder cancer.
    Mizutani Y, Yoshida O.
    J Urol; 1991 May; 145(5):1082-7. PubMed ID: 2016797
    [Abstract] [Full Text] [Related]

  • 2. Effect of PSK and its subfractions on peripheral blood lymphocytes mediated cytotoxicity against urinary bladder tumor cells.
    Mizutani Y, Nio Y, Yoshida O.
    J Urol; 1992 Nov; 148(5):1571-6. PubMed ID: 1433570
    [Abstract] [Full Text] [Related]

  • 3. Lysis of fresh human tumor cells by autologous peripheral blood lymphocytes and tumor-infiltrating lymphocytes activated by PSK.
    Kariya Y, Okamoto N, Fujimoto T, Inoue N, Kihara T, Sugie K, Yagita M, Kanzaki H, Mori T, Uchida A.
    Jpn J Cancer Res; 1991 Sep; 82(9):1044-50. PubMed ID: 1938599
    [Abstract] [Full Text] [Related]

  • 4. Sensitization of human bladder cancer cells to Fas-mediated cytotoxicity by cis-diamminedichloroplatinum (II).
    Mizutani Y, Yoshida O, Bonavida B.
    J Urol; 1998 Aug; 160(2):561-70. PubMed ID: 9679929
    [Abstract] [Full Text] [Related]

  • 5. Activation of human natural killer cells by the protein-bound polysaccharide PSK independently of interferon and interleukin 2.
    Kariya Y, Inoue N, Kihara T, Okamoto N, Sugie K, Mori T, Uchida A.
    Immunol Lett; 1992 Feb 15; 31(3):241-5. PubMed ID: 1372283
    [Abstract] [Full Text] [Related]

  • 6. Significance of cytotoxic activity of peripheral blood lymphocytes against autologous tumor cells in patients with bladder cancer.
    Mizutani Y, Okada Y, Yoshida O, Bonavida B.
    Cancer Biother Radiopharm; 1996 Dec 15; 11(6):385-91. PubMed ID: 10851499
    [Abstract] [Full Text] [Related]

  • 7. Modulation by cis-diamminedichloroplatinum (II) of the susceptibilities of human T24 lined and freshly separated autologous urinary bladder transitional carcinoma cells to peripheral blood lymphocytes and lymphokine activated killer cells.
    Mizutani Y, Nio Y, Yoshida O.
    J Urol; 1992 Feb 15; 147(2):505-10. PubMed ID: 1732632
    [Abstract] [Full Text] [Related]

  • 8. The streptococcal preparation OK-432 specifically augments the susceptibility of human urinary bladder tumor cells to autologous peripheral blood lymphocytes.
    Mizutani Y, Nio Y, Yoshida O.
    Cancer; 1992 Jun 15; 69(12):2999-3007. PubMed ID: 1591693
    [Abstract] [Full Text] [Related]

  • 9. Prognostic significance of circulating cytotoxic lymphocytes against autologous tumors in patients with bladder cancer.
    Mizutani Y, Okada Y, Terachi T, Yoshida O.
    J Urol; 1996 Mar 15; 155(3):888-92; discussion 892-4. PubMed ID: 8583600
    [Abstract] [Full Text] [Related]

  • 10. Adriamycin-mediated potentiation of cytotoxicity against freshly isolated bladder cancer cells by autologous non-activated peripheral blood lymphocytes and tumor infiltrating lymphocytes.
    Mizutani Y, Yoshida O, Miki T.
    J Urol; 1999 Dec 15; 162(6):2170-5. PubMed ID: 10569614
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Interferon-alpha-2b enhances the natural killer activity of patients with transitional cell carcinoma of the bladder.
    Carballido JA, Moltó LM, Manzano L, Olivier C, Salmerón OJ, Alvarez de Mon M.
    Cancer; 1993 Sep 01; 72(5):1743-8. PubMed ID: 8348503
    [Abstract] [Full Text] [Related]

  • 16. Interferon effect on cytotoxicity of peripheral blood and tumor-associated lymphocytes against human ovarian carcinoma cells.
    Allavena P, Introna M, Sessa C, Mangioni C, Mantovani A.
    J Natl Cancer Inst; 1982 Apr 01; 68(4):555-62. PubMed ID: 6175786
    [Abstract] [Full Text] [Related]

  • 17. Immunomodulation by orally administered protein-bound polysaccharide PSK in patients with gastrointestinal cancer.
    Nio Y, Tsubono M, Tseng CC, Morimoto H, Kawabata K, Masai Y, Shiraishi T, Imai S, Ohgaki K, Tobe T.
    Biotherapy; 1992 Apr 01; 4(2):117-28. PubMed ID: 1622733
    [Abstract] [Full Text] [Related]

  • 18. Antitumor effect of PSK: role of regional lymph nodes and enhancement of concomitant and sinecomitant immunity in the mouse.
    Ebina T, Kohya H, Ishikawa K.
    Jpn J Cancer Res; 1989 Feb 01; 80(2):158-66. PubMed ID: 2498250
    [Abstract] [Full Text] [Related]

  • 19. [Augmentation of cytotoxicity of tumor infiltrating lymphocytes by interleukin-2 in gastric cancer patients].
    Gotoh K.
    Nihon Geka Gakkai Zasshi; 1985 Dec 01; 86(12):1600-7. PubMed ID: 3878935
    [Abstract] [Full Text] [Related]

  • 20. Induction of bacillus-Calmette-Guérin-activated killer cells from human peripheral blood mononuclear cells against human bladder carcinoma cell lines in vitro.
    Thanhäuser A, Böhle A, Flad HD, Ernst M, Mattern T, Ulmer AJ.
    Cancer Immunol Immunother; 1993 Jul 01; 37(2):105-11. PubMed ID: 8319241
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 16.